Sobre 1 señal de compra con un rendimiento T+90 consolidado. Base de rendimiento: cierre del día siguiente a la publicación.
Historial de señales
Browse the complete record of transactions filed by Blume-Jensen Peter. Officer active across 1 company, notably Acrivon Therapeutics, Inc.. Cumulatively, 26 disclosures have been recorded. Split: 1 buy · 3 sells. Total volume traded: €100k. History available since 14 November 2022. The latest transaction was disclosed on 25 August 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Blume-Jensen Peter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
33.605 títulos@ 3,88 US$3.1% de su flujoCommon StockSEC:0001140361-23-027860:0
25 de 26 declaraciones
About Blume-Jensen Peter
Blume-Jensen Peter is a declarant linked to Acrivon Therapeutics, Inc. on XNAS, where the listed role is President and CEO. He has 23 filings in total, and within the sampled recent filings the purchases total 70538 EUR and the sales total 0 EUR, over a period from 2022-11-16 to 2026-05-26, with Retenue fiscale as the most frequent transaction nature.